Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Biotronics3D agreed to license Computer Aided Detection technology from Dublin City University in Ireland

Biotronics3D a London-based company, active in the research, development and marketing of advanced, image-based diagnostic devices has agreed to license Computer Aided Detection (CAD) technology from Dublin City University (DCU), an institution with an established international reputation in medical imaging research.  This new CAD tool when combined with the existing 3Dnet Colonoscopy solution creates an easy-to-use and cutting edge tool for CT Colonoscopy, focused on faster and more accurate cancer diagnosis based on CT examinations. 

Both Biotronics3D and DCU plan to use this licensing agreement as a basis for further engagement.  The agreement accelerates the company’s 3DNet Collaborative Network, a new strategic initiative to foster collaboration between Biotronics3D and other research institutions, companies and universities in the medical imaging space.

The CEO of Biotronics3D, Harry Hatzakis was keen to work with an organisation such as DCU with extensive research on the automated detection and assessment of oncology related abnormalities, to help develop and expand the 3DNet product line."Developing innovation carries many risks and in a fast moving market like global diagnostics, no company has enough resources or skills in-house to maintain a position at the forefront of innovation," Hatzakis said. "It's important to leverage skills that exist 'outside the company' in the delivery of products with aggressive go-to-market timeframes. In the modern knowledge based economy this is critical.  3DNet is ideally positioned today, to deliver a collaborative framework that could assist innovative companies or research groups in accelerating the engagement with the market," he said.

The CAD technology is the result of an extensive multi-year research programme led by Professor Paul Whelan. The project involved a broad multidisciplinary research team at the Centre for Image Processing and Analysis in DCU and was supported by leading consultant clinicians in Ireland, Dr. Helen Fenlon and Dr. Padraic Mac Mathuna.  Of the license agreement Professor Whelan stated, “We look forward to engaging with the Biotronics3D team to bring this DCU research to market.”

Richard Stokes CEO of Invent DCU Ltd., the technology transfer arm of DCU stated, “The medical imaging business has unique challenges, especially from a regulatory point of view.  We are grateful to leverage the expertise of Biotronics3D.”  Stokes added, “Invent is very keen to support industry-academia collaborations with strong business plans.  DCU acknowledges the strong support of Enterprise Ireland in the commercialization of this innovative technology.”

Source: Biotronics3D

You can discuss about Biotronics3D and its products & services in the Biotronics3D Company User Group